EDLB- Illumina Inc, OEM maintenance for the Illumina MiSeq i100 Plus Sequencer

The Centers for Disease Control and Prevention, under the Department of Health and Human Services, is seeking to award a sole-source, firm-fixed-price contract to Illumina, Inc. for five years of OEM maintenance and support services for its Illumina MiSeq i100 Plus Sequencer, serial number SH00687, located at the CDC’s Atlanta, Georgia facility. This non-competitive acquisition is justified under FAR 12.102 due to the proprietary nature of the sequencing system, which requires OEM-certified maintenance, diagnostic software, firmware updates, calibration protocols, and replacement parts that only Illumina, Inc. can provide. The total contract value is $68,862.65, covering all services including preventative maintenance, repairs, technical support, Field Application Scientist assistance, reagent replacement, and travel, structured as a base year with four option years exercisable at the government’s discretion. All performance, inspection, and acceptance occur on-site at the CDC’s Clifton Road facility, with compliance strictly defined by Illumina’s manufacturer standards rather than external federal or military specifications. The contract does not include a set-aside, and no socioeconomic or small business preferences apply. Documentation supporting the sole-source determination, including a Notice of Intent and Justification for Sole Source Procurement, was provided prior to solicitation. Submissions must be made electronically by June 22, 2026, to the designated contract specialist, with no formal competitive evaluation process applicable. The contracting officer and program officials will oversee contract administration, and no security clearances, organizational conflict of interest clauses, or unique packaging requirements are specified beyond adherence to OEM protocols. The contract is not broken down into CLINs or detailed pricing, and payment terms, invoicing methods, and accounting codes are not fully disclosed in the available information.